Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19

Intensive Care Med. 2020 Aug;46(8):1603-1606. doi: 10.1007/s00134-020-06088-1. Epub 2020 May 15.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use*
  • Betacoronavirus / physiology*
  • Blood Coagulation Disorders / drug therapy
  • Blood Coagulation Disorders / etiology*
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / immunology
  • Coronavirus Infections / physiopathology*
  • Critical Illness
  • Cytokine Release Syndrome / etiology
  • Hemostasis / physiology*
  • Humans
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / physiopathology*
  • SARS-CoV-2

Substances

  • Anticoagulants